Elkayam Lior, Matalon Albert, Tseng Chi-Hong, Axelrod Felicia
Dysautonomia Treatment and Evaluation Center, New York University School of Medicine, New York, NY, USA.
Am J Kidney Dis. 2006 Nov;48(5):780-6. doi: 10.1053/j.ajkd.2006.07.024.
One of the less well-defined complications of familial dysautonomia (FD) is chronic kidney disease (CKD). The goal of this report is to better define the prevalence and severity of kidney disease in this population and identify associated risk factors.
We conducted a retrospective analysis of the database of the Dysautonomia Treatment and Evaluation Center at New York University School of Medicine for patients with FD who were seen at ages 15, 20, 25, 30, 35, and 40 years. Estimated glomerular filtration rate (GFR) was compared with that of the general population. Changes in mean blood pressure from supine to erect at ages 15 and 20 years were analyzed for patients who eventually required dialysis therapy and compared with those of the other patients with FD. Percentage of patients requiring dialysis and duration of treatment also were analyzed.
Mean estimated GFR of each predefined age group was considerably less than that of the general population starting at age 15 years (P < 0.001). Patients with FD were more likely to develop stage 3, 4, or 5 CKD than the general population. Of patients who remained alive at age 25 years, 19% eventually required dialysis. Those who required dialysis therapy were less likely to have had a feeding gastrostomy tube placed (P < 0.001) and had much more pronounced postural changes in blood pressure (P < 0.0001) by age 15 years. For those requiring dialysis therapy, average duration of treatment was 9 months.
Patients with FD are far more likely than the general population to develop CKD. Patients with FD who eventually required dialysis showed a greater degree of orthostatic hypotension and were significantly less likely to have had a feeding gastrostomy tube placed for hydration before the age of 15 years. Dialysis therapy is not well tolerated in this population.
家族性自主神经功能障碍(FD)的一种定义尚不明确的并发症是慢性肾脏病(CKD)。本报告的目的是更明确该人群中肾脏疾病的患病率和严重程度,并确定相关危险因素。
我们对纽约大学医学院自主神经功能障碍治疗与评估中心数据库中15、20、25、30、35和40岁时就诊的FD患者进行了回顾性分析。将估计的肾小球滤过率(GFR)与普通人群进行比较。对最终需要透析治疗的患者,分析其15岁和20岁时从仰卧位到直立位的平均血压变化,并与其他FD患者进行比较。还分析了需要透析的患者百分比和治疗持续时间。
从15岁开始,每个预定义年龄组的平均估计GFR均显著低于普通人群(P <0.001)。与普通人群相比,FD患者更有可能发展为3、4或5期CKD。在25岁时仍存活的患者中,19%最终需要透析。那些需要透析治疗的患者在15岁时放置喂养胃造瘘管的可能性较小(P <0.001),并且血压的体位变化更为明显(P <0.0001)。对于那些需要透析治疗的患者来说,平均治疗持续时间为9个月。
FD患者比普通人群更易患CKD。最终需要透析的FD患者表现出更严重的体位性低血压,并且在15岁之前放置喂养胃造瘘管以补充水分的可能性显著降低。该人群对透析治疗的耐受性较差。